A. Kadambi

发表

A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy.

R. Jain, L. Munn, B. Stoll, 2003, Blood.

Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics

Rakesh K Jain, R. Jain, Y. Boucher, 2002, Science.

A Canadian Study of the Cost-Effectiveness of Apixaban Compared With Enoxaparin for Post-Surgical Venous Thromboembolism Prevention

A. Kadambi, N. Revankar, J. Patterson, 2013, Postgraduate medicine.

A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics

Christina M. Friedrich, W. Sasiela, J. Barrett, 2017, Gene regulation and systems biology.

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

R K Jain, R. Jain, D. Buerk, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy.

R. Jain, I. B. Borel Rinkes, D. Fukumura, 2002, Cancer research.

Systematic literature review of the real-world burden and use of chemotherapies for treatment of advanced or recurrent endometrial carcinoma.

A. Kadambi, Qi Zhao, E. Schiller, 2021 .

The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's Lymphoma.

A. Kadambi, J. Singer, N. Muszbek, 2016, Clinical therapeutics.

Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy.

Dai Fukumura, Rakesh K Jain, R. Jain, 2002, Cancer research.

Role of leukocytes and tissue-derived oxidants in short-term skeletal muscle ischemia-reperfusion injury.

T. Skalak, A. Kadambi, 2000, American journal of physiology. Heart and circulatory physiology.

Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A.

P. Carmeliet, R. Jain, D. Fukumura, 2001, Cancer research.

Vascular Endothelial Growth Factor (VEGF)-C Differentially Affects Tumor Vascular Function and Leukocyte Recruitment: Role of VEGF-Receptor 2 and Host VEGF-A 1

P. Carmeliet, R. Jain, D. Fukumura, 2001 .

Inclusion of Compliance and Persistence in Economic Models

D. Getsios, S. Sorensen, A. Kansal, 2012, Applied Health Economics and Health Policy.

Inclusion of compliance and persistence in economic models: past, present and future.

D. Getsios, S. Sorensen, A. Kansal, 2012, Applied health economics and health policy.

Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer

I. Chabot, A. Kadambi, Yun Su, 2021, BMC cancer.

Systems Modeling Applied to Candidate Biomarker Identification

Kapil Gadkar, K. Gadkar, A. Kadambi, 2011 .

Quantitative Systems Pharmacology: Applications and Adoption in Drug Development

Saroja Ramanujan, Kapil Gadkar, Ananth Kadambi, 2016 .

Role of VEGF-Receptor 2 and Host VEGF-A Affects Tumor Vascular Function and Leukocyte Recruitment: Vascular Endothelial Growth Factor (VEGF)-C Differentially

P. Carmeliet, R. Jain, D. Fukumura, 2001 .

A Canadian Study of the Cost-Effectiveness of Apixaban Compared With Enoxaparin for Post-Surgical Venous Thromboembolism Prevention

A. Kadambi, N. Revankar, J. Patterson, 2013, Postgraduate medicine.